| d-methadone |
opioid |
7th ECDD (1957) - Critical review |
| DELORAZEPAM |
benzodiazepine |
None
|
| delta-10-THC |
cannabinoid |
None
|
| delta-6a(10a)-THC |
cannabinoid |
None
|
| delta-6a(7)-THC |
cannabinoid |
None
|
| delta-7-THC |
cannabinoid |
None
|
| delta-8-THC |
cannabinoid |
Schedule I of the 1971 Convention
|
| Delta-9-tetrahydrocannabinol |
cannabinoid |
26th ECDD (1989) - Critical review, 27th ECDD (1991) - Critical review, 32nd ECDD (2001) - Pre-review, 33rd ECDD (2003) - Critical review, 34th ECDD (2006) - Critical review, 40th ECDD (2018) – Pre-review , 41st ECDD (2018) - Critical review |
| DESOMORPHINE |
opioid |
None
|
| Desoxypipradrol |
stimulant |
Added to surveillance list by 2nd WG meeting (2017)
|
| DET |
hallucinogen |
None
|
| Dexamphetamine |
stimulant |
17th ECDD (1970) - Critical review |
| Dextro-phenomorphan |
opioid |
11th ECDD (1961) - Critical review |
| Dextromethorphan |
opioid |
3rd ECDD (1952) - Critical review, 4th ECDD (1954) - Critical review, 16th ECDD (1969) - Critical review, 17th ECDD (1970) - Critical review, 35th ECDD (2012) - Pre-review |
| DEXTROMORAMIDE |
opioid |
None
|
| Dextropropoxyphene |
opioid |
13th ECDD (1964) - Critical review, 16th ECDD (1969) - Critical review, 17th ECDD (1970) - Critical review |
| Dextrorphan |
opioid |
4th ECDD (1954) - Critical review |
| Dezocine |
opioid |
25th ECDD (1989) - Critical review |
| Diacetylmorphine |
opioid |
2nd ECDD (1950) - Critical review |
| Diampromide |
opioid |
11th ECDD (1961) - Critical review |
| Diazepam |
benzodiazepine |
32nd ECDD (2001) - Critical review |
| Diclazepam |
benzodiazepine |
43rd ECDD (2020) - Critical review |
| Diethylthiambutene |
opioid |
6th ECDD (1956) - Critical review |
| Difebarbamate |
sedative |
23rd ECDD (1987) - Critical review |
| Difenoxin |
opioid |
20th ECDD (1974) - Critical review |
| Dihydrocodeine |
opioid |
2nd ECDD (1950) - Critical review, 3rd ECDD (1952) - Critical review |
| Dihydrodesoxymorphine |
opioid |
6th ECDD (1956) - Critical review |
| Dihydroetorphine |
opioid |
30th ECDD (1998) – Pre-review/a>, 31st ECDD (1999) - Critical review |
| Dihydrohydroxymorphinone |
opioid |
5th ECDD (1955) - Critical review |
| DIHYDROMORPHINE |
opioid |
None
|
| Dimenoxadol |
opioid |
9th ECDD (1959) - Critical review |
| DIMEPHEPTANOL |
opioid |
None
|
| Dimethylamphetamine |
stimulant |
22nd ECDD (1985) - Critical review |
| DIMETHYLTHIAMBUTENE |
opioid |
None
|
| Dioxaphetyl butyrate |
opioid |
9th ECDD (1959) - Critical review |
| Dipentylone |
stimulant |
46th ECDD (2023) - Critical review
|
| Diphenidine |
dissociative |
43rd ECDD (2020) - Critical review |
| Diphenoxylate |
opioid |
11th ECDD (1961) - Critical review, 19th ECDD (1973) - Critical review |
| Diphenoxylate preparations |
opioid |
11th ECDD (1961) - Critical review, 12th ECDD (1962) - Critical review, 14th ECDD (1965) - Critical review |
| Diphenoxylic acid |
opioid |
18th ECDD (1970) - Critical review |
| DIPIPANONE |
opioid |
None
|
| Diprenorphine |
other |
17th ECDD (1970) - Critical review |
| Dithienylbutylamines |
opioid |
3rd ECDD (1952) - Critical review |
| DMA |
hallucinogen |
None
|
| DMHP |
cannabinoid |
None
|
| DMT |
hallucinogen |
None
|
| DOC |
hallucinogen |
None
|
| DOC (2,5-Dimethoxy-4-chloroamfetamine) |
hallucinogen |
42nd ECDD (2019) - Critical review |
| DOET |
hallucinogen |
None
|
| DROTEBANOL |
opioid |
None
|
| Droxypropine |
opioid |
12th ECDD (1962) - Critical review, 13th ECDD (1964) - Critical review |